Therapy of empagliflozin plus metformin on T2DM mice shows no higher amelioration for glucose and lipid metabolism than empagliflozin monotherapy.

Wang, Zhiguo

Therapy of empagliflozin plus metformin on T2DM mice shows no higher amelioration for glucose and lipid metabolism than empagliflozin monotherapy. [electronic resource] - Life sciences Sep 2019 - 116622 p. digital

Publication Type: Journal Article

1879-0631

10.1016/j.lfs.2019.116622 doi


Animals
Benzhydryl Compounds--metabolism
Blood Glucose--drug effects
Diabetes Mellitus, Type 2--drug therapy
Disease Models, Animal
Drug Therapy, Combination--methods
Glucose--metabolism
Glucosides--metabolism
Lipid Metabolism--drug effects
Male
Metformin--metabolism
Mice
Mice, Inbred C57BL
Sodium-Glucose Transporter 2 Inhibitors--metabolism
Treatment Outcome